Table 1.
Condition | Synonym | Inheritance | Position | Gene | Number of Exons | Triplet Repeat Disorderb | Regions of High Penetrance |
---|---|---|---|---|---|---|---|
HD | AD | 4p16 | HTT | 67b | √ | Venezuela and worldwide | |
HDL1 | AD | 20p13 | PRNP | 2 | √ | ||
HDL2 | AD | 16q24 | JPH3 | 5b | √ | Black Africa | |
HDL4 | SCA17 | AD | 6q27 | TBP1 | 8b | √ | |
Spinocerebellar ataxias, i.e, SCA1, SCA2, SCA3, SCA8, SCA12 | AD | √ | |||||
DRPLA | NOD, HRS | AD | 12p13 | ATN1 | 10b | √ | Japan |
C9orf72 repeat expansions | Typically associated with FTD–ALS | AD | 9p21 | C9orf72 | 12c | Finnland, Sweden, Spain | |
Neuroferritinopathy | AD | 19q13 | FTL1 a | 4 | Cumbrian region of northern England | ||
Benign hereditary chorea | Thyroid‐lung syndrome | AD | 14q13 | TITF1 | 3 | ||
Benign hereditary chorea, type 2 | AD | Linked to chr. 8q21 | – | – | |||
ADCY5‐associated chorea | Familial dyskinesia with facial myokymia | AD | 3q21 | ADCY5 | 21 | ||
Primary familial brain calcification | Idiopathic basal ganglia calcification, Fahr's disease | AD | 8p11 | SLC20A2 | 11 | ||
5q32 | PDGFRB | 23 | |||||
22q12 | PDGFB | 7 | |||||
1q25 | XPR1 | 25 | |||||
Chorea‐acanthocytosis | Levine–Critchley syndrome | AR | 9q21 | VPS13A | 73 | ||
McLeod syndrome | x‐linked | Xp21 | XK | 3 | |||
HDL3 | AR | 4p15 | – | – | |||
RNF216‐mediated neurodegeneration | AR | 7p22 | RNF216 (TRIAD3) | 17 | |||
FRRS1L‐mediated chorea | AR | 9q31 | FRRS1L | 5 | |||
Wilson disease | Hepatolenticular degeneration | AR | 13q14 | ATP7B | 21 | ||
Ataxia telangiectsia | ATM syndrome | AR | 11q22 | ATM | 66 | ||
Aceruloplasminemia | AR | 3q24 | CP | 23 |
Disease‐causing triplet repeat located in exon 1 (HD and HDL2), exon 3 (HDL4/SCA17), exon 5 (DRPLA).
Also associated with hereditary hyperferritinemia cataract syndrome.
Expanded hexanucleotide repeat (GGGGCC) located between the noncoding exons 1a and 1b of C9orf72.
HD, Huntington's disease; AD, autosomal dominant; HDL, Huntington‐like disorder; HTT, huntingtin; SCA 17, spinocerebellar ataxia 17; DRPLA, Dentatorubral‐pallidoluysian atrophy; NOD, Naito‐Oyanagi disease; HRS, Haw River Syndrome; FTD–ALS, frontotemporal dementia–amyotrophic lateral sclerosis; AR, autosomal recessive.